Healthcare stocks advanced 0.3% at midday Tuesday. The Reserve Bank of Australia is expected to announce the anticipated interest rate decision later on the same day.
Opthea (ASX:OPT) completed the final week-52 patient visit in Coast, the first of two phase three trials evaluating a combination therapy candidate for wet age-related macular degeneration, an eye disease that can blur vision.
On the other hand, energy stocks were down 1.7%. Woodside Energy Group (ASX:WDS) extended losses from the Monday trading session, after it implied its final dividend could fall below expectations by as much as 20%.
Woodside held talks with several potential buyers of stakes in its Louisiana liquefied natural gas plant, including Tokyo Gas, Japan's JERA, and MidOcean Energy, Reuters reported citing multiple sources.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.